Regarding commonly used biomarkers in the clinical evaluation of RA, we observed statistically significant values for CRP, RF, and anti-CCP among patients with RA and healthy individuals serving as the control group in each of the populations. This evidence concerns the gene CRP and rheumatoid arthritis.